Literature DB >> 23232115

Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts.

Shinya Hirabara1, Toshihisa Kojima, Nobunori Takahashi, Masahiro Hanabayashi, Naoki Ishiguro.   

Abstract

Rheumatoid synovial fibroblasts (RSF) are activated by toll-like receptor (TLR) signaling pathways during the pathogenesis of rheumatoid arthritis (RA). Cathepsin K is highly expressed by RSF, and is known to play a key role in the degradation of type I and type II collagen. Cathepsin K is considered to be implicated in the degradation of bone and cartilage in RA. Recent observations have shown that hyaluronan (HA) is an important inhibitor of inflammation. In the present study, we show that lipopolysaccharide (LPS) stimulation significantly increases cathepsin K expression by real-time PCR and western blotting analysis via a TLR-4 signaling pathway. Furthermore, we demonstrate that HA suppresses LPS-induced cathepsin K expression, which is dependent on CD44 but not intercellular adhesion molecule-1 (ICAM-1) interaction. We also show that HA suppresses LPS-induced matrix metalloproteinase-1 (MMP-1) expression, which is dependent on both CD44 and ICAM-1 interaction. We conclude that the anti-inflammatory effect of HA occurs through crosstalk between more than one HA receptor. Our study provides evidence for HA mediated suppression of LPS-induced cathepsin K and MMP-1 expression, supporting a protective effect of HA in RA.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232115     DOI: 10.1016/j.bbrc.2012.12.003

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Effects of 4-methylumbelliferone and high molecular weight hyaluronic acid on the inflammation of corneal stromal cells induced by LPS.

Authors:  Fang Li; Peng Hao; Guangjie Liu; Weiyi Wang; Ruifang Han; Zhixin Jiang; Xuan Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-06       Impact factor: 3.117

2.  A small molecule, odanacatib, inhibits inflammation and bone loss caused by endodontic disease.

Authors:  Liang Hao; Wei Chen; Matthew McConnell; Zheng Zhu; Sheng Li; Michael Reddy; Paul D Eleazer; Min Wang; Yi-Ping Li
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

3.  Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan.

Authors:  Shinya Ishizuka; Saho Tsuchiya; Yoshifumi Ohashi; Kenya Terabe; Emily B Askew; Naoko Ishizuka; Cheryl B Knudson; Warren Knudson
Journal:  J Biol Chem       Date:  2019-07-03       Impact factor: 5.157

Review 4.  Hyaluronan interactions with innate immunity in lung biology.

Authors:  Robert M Tighe; Stavros Garantziotis
Journal:  Matrix Biol       Date:  2018-02-02       Impact factor: 11.583

5.  The HIV Protease Inhibitor Saquinavir Inhibits HMGB1-Driven Inflammation by Targeting the Interaction of Cathepsin V with TLR4/MyD88.

Authors:  John P Pribis; Yousef Al-Abed; Huan Yang; Domokos Gero; Hongbo Xu; Marcelo F Montenegro; Eileen M Bauer; Sodam Kim; Sangeeta S Chavan; Changchun Cai; Tunliang Li; Petra Szoleczky; Csaba Szabo; Kevin J Tracey; Timothy R Billiar
Journal:  Mol Med       Date:  2015-09-02       Impact factor: 6.354

Review 6.  Biomaterial-mediated modification of the local inflammatory environment.

Authors:  Shane Browne; Abhay Pandit
Journal:  Front Bioeng Biotechnol       Date:  2015-05-15

Review 7.  Cancer microenvironment and inflammation: role of hyaluronan.

Authors:  Dragana Nikitovic; Maria Tzardi; Aikaterini Berdiaki; Aristidis Tsatsakis; George N Tzanakakis
Journal:  Front Immunol       Date:  2015-04-14       Impact factor: 7.561

8.  Hyaluronan Inhibits Tlr-4-Dependent RANKL Expression in Human Rheumatoid Arthritis Synovial Fibroblasts.

Authors:  Tatsuo Watanabe; Nobunori Takahashi; Shinya Hirabara; Naoki Ishiguro; Toshihisa Kojima
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

9.  A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis.

Authors:  Justin R Savage; Abigail Pulsipher; Narayanam V Rao; Thomas P Kennedy; Glenn D Prestwich; Maria E Ryan; Won Yong Lee
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

Review 10.  The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical Translation.

Authors:  May Griffith; Mohammad M Islam; Joel Edin; Georgia Papapavlou; Oleksiy Buznyk; Hirak K Patra
Journal:  Front Bioeng Biotechnol       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.